blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3044317

EP3044317 - ANTISENSE OLIGOMERS AND METHODS FOR TREATING SMN-RELATED PATHOLOGIES [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  19.05.2017
Database last updated on 13.09.2024
Most recent event   Tooltip19.05.2017Withdrawal of applicationpublished on 21.06.2017  [2017/25]
Applicant(s)For all designated states
The University Of Western Australia
35 Stirling Highway
Crawley, WA 6009 / AU
[2016/29]
Inventor(s)01 / WILTON, Stephen Donald
18 Spey Road
Applecross, Western Australia 6153 / AU
02 / FLETCHER, Sue
14 Roberts Street
Bayswater, Western Australia 6053 / AU
03 / PRICE, Loren Louise
132 Daglish Street
Wembley, Western Australia 6014 / AU
04 / MITRPANT, Chalermchai
444/57 Charoenkrung
85 Charoenkrung Road
Wat Phrayakrai
Bangkholam
10120 Bangkok / TH
 [2016/29]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2016/29]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date14844805.312.09.2014
[2016/29]
WO2014AU00907
Priority number, dateAU2013090352413.09.2013         Original published format: AU 2013903524
[2016/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015035460
Date:19.03.2015
Language:EN
[2015/11]
Type: A1 Application with search report 
No.:EP3044317
Date:20.07.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 19.03.2015 takes the place of the publication of the European patent application.
[2016/29]
Search report(s)International search report - published on:AU19.03.2015
ClassificationIPC:C12N15/113, C07H21/00, A61K31/712, A61K31/7125, A61P21/00, A61P25/02
[2016/29]
CPC:
A61K31/712 (EP,US); A61K31/7125 (EP,US); A61P21/00 (EP);
A61P25/02 (EP); A61P43/00 (EP); C12N15/111 (EP,US);
C12N15/113 (EP,US); C12N2310/11 (EP,US); C12N2310/31 (US);
C12N2310/3233 (EP,US); C12N2320/33 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/29]
TitleGerman:ANTISENSE-OLIGOMERE UND VERFAHREN ZUR BEHANDLUNG VON PATHLOGIEN IM ZUSAMMENHANG MIT SMN[2016/29]
English:ANTISENSE OLIGOMERS AND METHODS FOR TREATING SMN-RELATED PATHOLOGIES[2016/29]
French:OLIGOMÈRES ANTISENS ET PROCÉDÉS DE TRAITEMENT DE PATHOLOGIES LIÉES À SMN[2016/29]
Entry into regional phase31.03.2016National basic fee paid 
31.03.2016Search fee paid 
31.03.2016Designation fee(s) paid 
31.03.2016Examination fee paid 
Examination procedure31.03.2016Examination requested  [2016/29]
18.10.2016Amendment by applicant (claims and/or description)
02.05.2017Application withdrawn by applicant  [2017/25]
Fees paidRenewal fee
27.09.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2013086207  (UNIV OHIO STATE [US], et al);
 [L]SG189598  (SINGAPORE HEALTH SERV PTE LTD [SG])
 [X]  - MITRPANT, C. ET AL., "Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy", PLOS ONE, (201304), vol. 8, no. ISSUE, XP002733112

DOI:   http://dx.doi.org/10.1371/journal.pone.0062114
 [X]  - ZHOU, H. ET AL., "A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice", HUMAN GENE THERAPY, (201303), vol. 24, pages 1 - 12, XP055324641

DOI:   http://dx.doi.org/10.1089/hum.2012.211
 [X]  - HUA, Y. ET AL., "Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice", THE AMERICAN JOURNAL OF HUMAN GENETICS, (2008), vol. 82, pages 834 - 848, XP055274438

DOI:   http://dx.doi.org/10.1098/rsob.120133
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.